AzTrials
AzTrials

Abortion EarlyEMAVIDNCT03417362

Delivery of Audiovisual Information on Early Medical Abortion

A study testing Animation in people with Abortion Early and Abortion in First Trimester, run by NHS Lothian at 3 sites in 3 countries.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The majority of abortions in the United Kingdom (UK) are performed before 9 weeks (63 days) gestation using a method known as Early Medical Abortion (EMA). EMA involves an assessment visit and provision of two types of medication . Read more about this study

Who is it for?
Ages 16 years and older, women onlyHealthy volunteers can take part
Conditions the study is for
Abortion Early, Abortion in First Trimester
What is being tested?
Animation
Could I receive a placebo?
No, everyone receives an active treatment
How many people
174 participants
Where
3 sitesin 3 countries
Study dates
5 Mar 2018to 12 Mar 2019
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 16 years and older
  • Women only
  • Healthy volunteers accepted
  • Child, Adult, Older adult

Who may be able to join

  • Female
  • Pregnant
  • Presenting for Termination of Pregnancy
  • Aged 16 years or over
  • Able to understand English (the video is in English, and whilst translations are available, their content has been altered to reflect abortion laws in other countries)
  • Gestation of 9 weeks (63 days) or less on ultrasound scan
  • Able to provide consent

Who cannot join

  • Non pregnant
  • Pregnancy of Unknown Location
  • Uncertain of decision or wishing to continue pregnancy
  • 15 years old or younger
  • Unable to understand English
  • Gestation 9 weeks and 1 day (64 days) or greater on ultrasound scan.
  • Unable to provide consent

Trial locations and contacts

3 sites in 3 countries.

3 sites in 3 countries

France1 site
  • Assistance Publique Hopitaux de Paris

    Paris

Other trials in France

Sweden1 site
  • Karolinska University Hospital

    Stockholm

Other trials in Sweden

United Kingdom1 site
  • Chalmers Centre for Sexual and Reproductive Health

    Edinburgh

Other trials in United Kingdom

About this study

Official title: Delivery of Audiovisual Information on Early Medical Abortion to Women in Europe Via Digital Technology: is it Acceptable and Informative?

The majority of abortions in the United Kingdom (UK) are performed before 9 weeks (63 days) gestation using a method known as Early Medical Abortion (EMA). EMA involves an assessment visit and provision of two types of medication .

The assessment visit usually involves Ultrasound to confirm gestation, detailed personal history, safeguarding assessment and contraception planning, before arranging treatment and follow up.

Read more

The process is long and lots of information is given to women attending the service. In NHS Lothian (National Health Service, Lothian Health Board), the average appointment length for combined assessment and provision of the first part of treatment is 3 hours.

Despite how common abortion is ( 1 in 3), many women presenting for abortion care are not aware of what the procedure will involve. This may in part to the social stigma surrounding abortion and unintended pregnancy in general. This stigma can in turn result in feelings of anxiety and shame about the decision to terminate a pregnancy.

There is evidence that short videos shown to patients prior to abortion or contraception consultations can improve their ability to recall information and can make them feel more confident about the procedure.

Additionally, abortion care providers have found patients who have seen videos to be better prepared and informed and this allows consultations to progress more easily and allow greater time for discussion of contraceptive methods.

We have prepared a video approximately 3 minutes in length to provide information about EMA. It summarises the process described above using simple language and animated characters. The video has been translated into French, Portuguese and Swedish and has been adapted to reflect subtle differences in practice and law in these countries. We have partners in services in these three countries who will be conducting the trial there in accordance with this protocol and their own local ethics and clinical governance requirements.

Read the detailed description

Despite abortion being a common medical procedure, many women do not have access to good quality, reliable information about it. This may stem from the stigma and shame surrounding the procedure leading to less community knowledge and experience sharing compared to other medical conditions, for example diabetes or heart disease.

Lack of knowledge and understanding about a medical procedure can cause anxiety, distress and confusion when seeing a healthcare professional, which in turn can prolong consultations.

By introducing the short video animation, we are hoping that this will give the women attending the service a basic level of knowledge about Early Medical Abortion, reduce the anxiety and worry they are experiencing by informing them, and make them feel more confident and clear during their consultations.

It has been shown in other studies that short videos in contraception and abortion consultations can have this impact, but a randomised control trial methodology has never been applied to this intervention.

In a standard initial Early Medical Abortion visit a patient will experience the following Patient Journey:

  1. Arrival and registration
  2. Waiting for appointment in waiting room
  3. Ultrasound scan to determine gestation
  4. Self taken vulvovaginal swab for Chlamydia and Gonorrhoea screening
  5. Blood tests for : HIV, Syphilis, Full Blood Count, Blood Group
  6. Return to the waiting room
  7. Assessment consultation with healthcare professional (i.e. Specialist Nurse or Doctor)
  8. Return to the waiting room
  9. Treatment Consultation: to receive 'first part' of treatment i.e. Mifepristone and dates for 'second part' 24-48 hours later.
  10. Leave department

In the study, the above will happen, however patients will be given a participant information sheet (at step 1 above )when they arrive in department to register. At Step 6, when the patient has returned to the waiting room, eligible patients will be approached and asked if they would like to participate and if so will be randomised to 'standard of care' or 'intervention' (i.e. the video). They will resume the Patient Journey above and will again be approached at Step 8 or Step 10 to complete the short questionnaire.

For the questionnaire: a single researcher will record, on a standard proforma, what information the subject had taken from the consultation and its accuracy, and the overall acceptability of the consultation using a Likert scale to quantify descriptors such as 'helpful', 'informative', 'understandable', 'impersonal', 'sympathetic' 'unsympathetic' etc.

The number of women declining to participate in the study would be recorded .

Being tested
Animation
Keywords
education, audiovisual, information, acceptability

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • AnimationOther

    3 minute video describing and explaining early medical abortion, followed by questionnaire

Study groups in NCT03417362
Study groupRoleWhat they receive
AnimationOtherAnimation describing process of early medical abortion, what to expect, how to take medicines. This is prior to consultation.
Receives: Other: Animation
StandardNo interventionStandard of Care - no animation ,standard consultation only.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Is the recall of key information about EMA similar after watching the video compared to following face to face contact with a clinician?

    The patient will be asked to recall any facts that they learned from watching the video/from the consultation and this will be compared to a list held by the researcher. A numerical score for points recalled will be generated for each patient.

    Measured: Immediately during questionnaire

Secondary outcomes (2)
  1. What place/ role do women who watch the video feel that it has (if any)?

    Open ended questions in the questionnaire to ask participants their thoughts on video and when/where it could be viewed in relation to their treatment. The participant can select an answer from a list of options or volunteer their own.

    Measured: Immediately during questionnaire

  2. Do women find it acceptable to receive information about Early Medical Abortion (EMA) via an animated video?

    Likert Scale completed with researcher around a series of different statements relating to their acceptability of the video. Positive responses will be grouped and an overall result of 'acceptable' or 'not acceptable' will be assigned per case.

    Measured: Immediately during questionnaire

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted31 Jan 2018
  2. Study start5 Mar 2018
  3. Primary completion12 Mar 2019
  4. Study completion12 Mar 2019

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Health services research
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
174 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03417362
Sponsor's protocol ID
AC17102
Other IDs
235487, 2018/0060, 18/NS/0016
Acronym
EMAVID
Status last verified
Mar 2019
First submitted
24 Jan 2018
Last updated
13 Mar 2019
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No: Only anonymised responses to questionnaire will be shared between sites.

Publications

  • Michie L, Cameron ST, Glasier A, Johnstone A. Giving information about the contraceptive implant using a DVD: is it acceptable and informative? A pilot randomised study. J Fam Plann Reprod Health Care. 2016 Jul;42(3):194-200. doi: 10.1136/jfprhc-2015-101186. Epub 2015 Aug 6.

    PubMed 26250853
  • Powell-Jackson R, Glasier A, Cameron ST. Benefits of using a digital video disk for providing information about abortion to women requesting termination of pregnancy. Contraception. 2010 Jun;81(6):537-41. doi: 10.1016/j.contraception.2010.01.015. Epub 2010 Feb 19.

    PubMed 20472123
  • Reynolds-Wright JJ, Belleuvre F, Daberius A, Faucher P, Gemzell-Danielsson K, Cameron ST. Information on early medical abortion for women using an audiovisual animation vs face-to-face consultation: A consortium randomized and quasi-randomized trial. Acta Obstet Gynecol Scand. 2020 Dec;99(12):1611-1617. doi: 10.1111/aogs.13944. Epub 2020 Jul 12.

    PubMed 32573767

Questions about this trial

What is this clinical trial studying?

A study testing Animation in people with Abortion Early and Abortion in First Trimester, run by NHS Lothian at 3 sites in 3 countries.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 7 inclusion and 7 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 13 Mar 2019. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 3 sites in France, Sweden, United Kingdom. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Is the recall of key information about EMA similar after watching the video compared to following face to face contact with a clinician? (time frame: Immediately during questionnaire). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT03417362, which also lists 3 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 13 Mar 2019.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in